Literature DB >> 8475058

Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene.

W R Shehee1, P Oliver, O Smithies.   

Abstract

Thalassemias are hereditary anemias caused by mutations that disturb the normal 1:1 balance of alpha- and beta-globin chains that form hemoglobin. We have disrupted the major adult beta-globin gene (b1) in mouse embryonic stem cells by using homologous recombination to insert selectable sequences into the gene. Mice homozygous for this insertional disruption of the b1 gene (Hbbth-2/Hbbth-2) are severely anemic and die perinatally. In contrast, approximately 60% of mice homozygous for deletion of the same gene (Hbbth-1/Hbbth-1) survive to adulthood and are much less anemic [Skow, L. C., Burkhart, B. A., Johnson, F. M., Popp, R. A., Goldberg, S. Z., Anderson, W. F., Barnett, L. B. & Lewis, S. E. (1983) Cell 34, 1043-1052]. These different phenotypes have implications for the control of beta-globin gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475058      PMCID: PMC46262          DOI: 10.1073/pnas.90.8.3177

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Recombinant fragment assay for gene targetting based on the polymerase chain reaction.

Authors:  H S Kim; O Smithies
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

2.  Developmental regulation of beta-globin gene switching.

Authors:  O R Choi; J D Engel
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

3.  The beta-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner.

Authors:  G Blom van Assendelft; O Hanscombe; F Grosveld; D R Greaves
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

4.  Regulated expression of genes inserted at the human chromosomal beta-globin locus by homologous recombination.

Authors:  A K Nandi; R S Roginski; R G Gregg; O Smithies; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

6.  A 66-base pair insert bridges the deletion responsible for a mouse model of beta-thalassemia.

Authors:  S Z Goldberg; D Kuebbing; D Trauber; M P Schafer; S E Lewis; R A Popp; W F Anderson
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

7.  Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine.

Authors:  J B Whitney
Journal:  Biochem Genet       Date:  1978-08       Impact factor: 1.890

8.  Compensatory increase in levels of beta minor globin in murine beta-thalassemia is under translational control.

Authors:  M J Curcio; P Kantoff; M P Schafer; W F Anderson; B Safer
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

9.  Beta-thalassemia with exceptionally high hemoglobin A2. Differential expression of the delta-globin gene in the presence of beta-thalassemia.

Authors:  M H Steinberg; M B Coleman; J G Adams
Journal:  J Lab Clin Med       Date:  1982-10

10.  HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells.

Authors:  M Hooper; K Hardy; A Handyside; S Hunter; M Monk
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

View more
  28 in total

1.  Efficient repetitive alteration of the mouse Huntington's disease gene by management of background in the tag and exchange gene targeting strategy.

Authors:  J A Cearley; P J Detloff
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

Review 2.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

3.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

4.  Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.

Authors:  Trisha Dasgupta; Mary E Fabry; Dhananjay K Kaul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

Review 5.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

6.  IL-2 pathway blocking in combination with anti-CD154 synergistically establishes mixed macrochimerism with limited dose of bone marrow cells and prolongs skin graft survival in mice.

Authors:  Jeong-hoon Lee; Jongwon Ha; Shi-hwa Kim; Sang Joon Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

7.  Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci.

Authors:  T Trimborn; J Gribnau; F Grosveld; P Fraser
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

8.  Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Tara Schmidt; Jianzhu Chen; Phillip A Sharp; Dean Tantin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Humanized Mouse Model of Cooley's Anemia.

Authors:  Yongliang Huo; Sean C McConnell; Shan-Run Liu; Rui Yang; Ting-Ting Zhang; Chiao-Wang Sun; Li-Chen Wu; Thomas M Ryan
Journal:  J Biol Chem       Date:  2008-12-19       Impact factor: 5.157

10.  Substitution of the human beta-spectrin promoter for the human agamma-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice.

Authors:  D E Sabatino; A P Cline; P G Gallagher; L J Garrett; G Stamatoyannopoulos; B G Forget; D M Bodine
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.